HIGHLIGHTS
- who: Kuan-Chung Chen et al. from the School of Pharmacy, China Medical University, Taichung, Taiwan have published the Article: In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine, in the Journal: (JOURNAL) of 30/04/2014
- what: The authors propose isopraeroside IV and aurantiamide acetate as potential lead compounds for further study in drug development process with the PARP-1 protein. The authors aim to investigate the potent TCM candidates for PARP-1 protein.
SUMMARY
Poly(ADP-ribose) polymerases (PARPs) are nuclear enzymes which catalyze the poly . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.